Background: The U.S. heart allocation system ranks candidates with only 6 treatment-based categorical statuses and ignores many objective patient characteristics. Objectives: This study sought to determine the effectiveness of the standard 6-status ranking system and several novel prediction models in identifying the most urgent heart transplant candidates. Methods: The primary outcome was death before receipt of a heart transplant. The accuracy of the 6-status system was evaluated using Harrell\u27s C-index and log-rank tests of Kaplan-Meier estimated survival by status for candidates listed postpolicy (November 2018 to March 2020) in the Scientific Registry of Transplant Recipients data set. The authors then developed Cox proportiona...
The new adult heart allocation policy was approved in 2016 and implemented in October 2018, so its e...
Heart transplantation is life saving for patients with end-stage heart disease. However, a number of...
International audienceBackground. Heart transplantation is the gold-standard treatment for end-stage...
ObjectivesWe sought to investigate the actual survival of patients with end-stage heart failure list...
International audienceSeveral risk scores exist to help identify best candidate recipients for heart...
Purpose: Candidate selection and donor allocation should promote equitable access to heart transplan...
BACKGROUND: Heart transplant programs and regulatory entities require highly accurate performance me...
International audienceIntroduction: Heart transplantation (HT) remains the gold-standard treatment b...
BACKGROUND: Heart transplant programs and regulatory entities require highly accurate performance me...
Background: Primary graft dysfunction (PGD) is a major cause of morbidity and mor...
The shortage of donor hearts emphasizes the importance of an optimal selection among candidates for ...
Importance: With continuing improvements in medical devices and more than a decade since the 2006 Un...
Background:The US heart allocation system ranks candidates using six categorical status levels. Tran...
PurposeThe Seattle Heart Failure Model (SHFM), the Interagency Registry for Mechanically Assisted Ci...
<div><p>Background</p><p>Heart transplantation is life saving for patients with end-stage heart dise...
The new adult heart allocation policy was approved in 2016 and implemented in October 2018, so its e...
Heart transplantation is life saving for patients with end-stage heart disease. However, a number of...
International audienceBackground. Heart transplantation is the gold-standard treatment for end-stage...
ObjectivesWe sought to investigate the actual survival of patients with end-stage heart failure list...
International audienceSeveral risk scores exist to help identify best candidate recipients for heart...
Purpose: Candidate selection and donor allocation should promote equitable access to heart transplan...
BACKGROUND: Heart transplant programs and regulatory entities require highly accurate performance me...
International audienceIntroduction: Heart transplantation (HT) remains the gold-standard treatment b...
BACKGROUND: Heart transplant programs and regulatory entities require highly accurate performance me...
Background: Primary graft dysfunction (PGD) is a major cause of morbidity and mor...
The shortage of donor hearts emphasizes the importance of an optimal selection among candidates for ...
Importance: With continuing improvements in medical devices and more than a decade since the 2006 Un...
Background:The US heart allocation system ranks candidates using six categorical status levels. Tran...
PurposeThe Seattle Heart Failure Model (SHFM), the Interagency Registry for Mechanically Assisted Ci...
<div><p>Background</p><p>Heart transplantation is life saving for patients with end-stage heart dise...
The new adult heart allocation policy was approved in 2016 and implemented in October 2018, so its e...
Heart transplantation is life saving for patients with end-stage heart disease. However, a number of...
International audienceBackground. Heart transplantation is the gold-standard treatment for end-stage...